Pharma IQ Members

17 results
of 2
Cristina Falcão

Big Pharma Logistics: E-Pedigree, RFID and Cell-Phones

Globally, commercial goods, pharmaceutical, biomedical/biologics including commercial and military aerospace industries all experience product infiltration with unknown, non-genuine, stylish imitation, countless after-market knock-offs. Within these mentioned applications, the basic method of applying an adhered seal is lacking and insufficient as the seal is quite easily substituted or replaced.

by: Cristina Falcão
Published: October 23, 2012
Tags: Cristina Falcão, pharma logistics, logistics, RFID


Cristina Falcão

Fighting the Battle against Drug Counterfeiting; How Document Automation Can Assist

Today’s Supply chain companies demand a near perfect order record to reduce the cost of labor, transportation and errors within their distribution centers. We interviewed Tom Napier from PSI Engineering, which provides tailored products to the pharma industry.Their systems not only reduce costs, but also helpfight counterfeiting and secure the integrity of the pharmaceutical supply chain.

by: Cristina Falcão
Published: August 29, 2012
Tags: Cristina Falcão, Tom Napier, PSI Engineering, droug counterfeiting, counterfeiting, supply chain, document automation


Cristina Falcão

Pharmacy Logistics Knockout Reimbursement Schemes

It is pretty amazing how, with only one strike, the pharmacy logistics of an entire country knocked out all the reimbursement schemes and it took two years to understand the problem and try to fix it to some extent. I was so fascinated by this mystery that I decided to investigate and published my conclusions some years back

by: Cristina Falcão
Published: July 23, 2012
Tags: Cristina Falcão, payers, invalid prescriptions, pharmacy logistics, reimbursement schemes


Cristina Falcão

The Portuguese Pharmacy and Supply Chain

We don’t handle drugs inside the pharmacy, we have packages, sealed, and with the bar code, batch number and expiration date in the label and in the blisters or any other pharmaceutical form labels inside the outer package.

by: Cristina Falcão
Published: June 25, 2012
Tags: Cristina Falcão, portuguese pharmacy, supply chain, INFARMED, OTC, counterfeited medicines, pharmacy


Cristina Falcão

Hey Big Pharma, Hey Big Spender! Steps to Improve Pharma R&D ROI

In times of global recession pharma industry was not immune to the direct and indirect effects of the economic crisis. It is not just about dry pipelines and skyrocketing R&D costs; it is also about the profound changes in global healthcare systems.

by: Cristina Falcão
Published: May 21, 2012
Tags: Cristina Falcão, pharma R&D, virtual pharma, cloud sourcing, translational pharmaceutics, clustering, R&D, R&D costs


Cristina Falcão

A Revolutionary Paradigm Shift in Big Pharma's Organisational Development

A paradigm is the conceptual framework upon which we build our world; it is built upon past experiences; if we are not willing to make shifts in our paradigms, we will remain stagnate in our growth; a paradigm shift is a change from one way of thinking to another; it is something that does not happen like self generation it is driven by change.

by: Cristina Falcão
Published: April 24, 2012
Tags: Big Pharma's Organisational Development, Cristina Falcão, paradigm shift, pharma business models, pharma business model, M&A, downsizing, virtual model, continuous manufacturing, Big Pharma, R&D models, commercial approach


Cristina Falcão

Taxing “Globesity” To Save Our Children

Will “Fat taxes” affect consumption, and eventually obesity? The impact of imposing taxes on the consumption of certain foods depends on the responsiveness of consumers to price changes, i.e. price elasticity. It is difficult to predict how consumers will react to price changes caused by taxation.

by: Cristina Falcão
Published: March 24, 2012
Tags: Cristina Falcão, obesity epidemic, obesity costs, obesity, fat taxes, taxation, bariatric surgery


Cristina Falcão

Big Pharma Cannot Afford to be Lost in Translation

Since more and more clinical research and drug manufacturing are being done in multiple countries and in multiple languages, quality language services can help bring a drug to market faster, and can help streamline the clinical trial process. Translation may be required at many stages, including clinical research, regulatory submission and review, production and marketing.

by: Cristina Falcão
Published: February 16, 2012
Tags:


Cristina Falcão

Personalized Medicine –A Game with More Than One Nash Equilibrium

PM is no longer about the pharma industry alone – the players/stakeholders go far beyond the pharmaceutical and biotechnology industries, presenting a new challenge in assembling diverse technologies and partners working together. Success in this space will require new approaches, new relationships, and new ways of thinking.

by: Cristina Falcão
Published: January 12, 2012
Tags: personalized medicine, Cristina Falcão, personalised medicine, human genome


Cristina Falcão

Orphan Drugs – Reinventing Economies of Scale

The hardest area to improve is measurement and evaluation - pricing and reimbursement of orphan drugs are under payers’ scrutiny.

by: Cristina Falcão
Published: November 16, 2011
Tags: Cristina Falcão, orphan drugs, orphan drugs market, market access, pricing, rare diseases, marketing authorization, personalized medicine, reimbursement


17 results
of 2